Clinical Trial Update: Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy

View source ↗

Summary

A clinical trial sponsored by the University of Sydney is recruiting to evaluate radio-opaque contrast agents intended to target liver cancer during radiation t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Snippet

Sponsor: University of Sydney | Conditions: Liver Neoplasm | Status: RECRUITING